CNS PHARMACEUTICALS INC (CNSP)
US18978H3003 - Common Stock
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming H.C. Wainwright 26th Annual Global Investment Conference. The event is slated for Sept. 9–11, 2024, in New York. According to the announcement, CEO […]
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted in the most recent episode of IBN’s BioMedWire Podcast. During the episode, CNS Pharmaceuticals CEO John Climaco talks with podcast host Carmel Fisher to explain what sets […]
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that CEO John Climaco will present and discuss recent corporate events at the upcoming LIVE! with Webull Corporate Connect: Virtual Biotech Investor Webinar. The presentation is […]
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024
CNS Pharmaceuticals just reported results for the second quarter of 2024.
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CNS Pharmaceuticals (NASDAQ:CNSP) just reported results for the second quarter ...
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue
A Microsoft Office outage has workers annoyed as its causing problems with them being able to use the company's services.
SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis
SoundHound AI stock is up on Tuesday as SOUN investors react well to the company's voice assistant coming to Stellantis vehicles.
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
CNS Pharmaceuticals stock is falling hard on Tuesday as CNSP investors aren't happy about its latest license expansion.